The company added that the Stabilimax Dynamic Spine Stabilization System has also received FDA permission to resume a multi-center, randomized, controlled clinical trial, comparing posterior dynamic stabilization with the system to traditional spinal fusion stabilization to treat degenerative lumbar spinal stenosis.
The company has enrolled more than 100 patients in the trials to date.
Read the release about the Applied Spine posterior dynamic stabilization device.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
